Rheum in Bloom

A disturbing conversation with another health care provider


 

References

She didn’t think she needed a lumbar puncture to confirm her diagnosis. She hadn’t bothered to order Lyme serologies or to look for previous results. “We take the patient’s word for it,” she smugly told me. She had full confidence that her diagnosis was correct, because “we see this all the time.” When I said I thought, common things being common, that the cigarette smoking was the most likely culprit for the changes, her response was: “Common things being common, Lyme disease is pretty common around here.” On the question of why the patient was getting oral antibiotics rather than IV antibiotics per Infectious Diseases Society of America guidelines for CNS Lyme, the response I got was again, that she sees this “all the time, and they do respond to oral antibiotics.”

I think the worst part was that when I pointed out that the preponderance of other doctors (two primary care physicians, two infectious disease doctors, another neurologist, another rheumatologist, and myself) did not agree with the diagnosis, her reply was to say that “the ID docs around here are way too conservative when it comes to treating chronic Lyme.”

Of course, she could very well be correct in her diagnosis. However, the conceit with which she so readily accused the ID specialists of being “too conservative” when she clearly did not do the necessary work herself (LP, serologies, etc.) just rubs me the wrong way. Lazy and arrogant make a horrible combination.

I politely disagreed and ended the conversation, but I was so worked up about the situation that I decided to write about it, thereby demonstrating the same bad behavior I claim to dislike. I am afraid at this stage in my professional development magnanimity is not a quality that I yet possess. Hopefully, I will not have many opportunities to demonstrate my lack of it.

Dr. Chan practices rheumatology in Pawtucket, R.I.

Pages

Recommended Reading

Medicare @ 50: Popular with patients; problematic for physicians
MDedge Rheumatology
Varying cutoffs of vitamin D add confusion to field
MDedge Rheumatology
FDA approves peramivir, first IV flu antiviral
MDedge Rheumatology
FDA: Ease ban on blood donation by MSM
MDedge Rheumatology
Rx for specialists: Know how ACA affects patients’ ability to pay for meds
MDedge Rheumatology
Diabetes drug liraglutide approved for weight loss indication
MDedge Rheumatology
Giving patients ownership of data key to solving health IT woes
MDedge Rheumatology
FDA approves IV antibacterial for complicated UTIs, abdominal infections
MDedge Rheumatology
Higher opioid doses associated with increase in depression
MDedge Rheumatology
Qualifying as an expert
MDedge Rheumatology